Figure 6.
Details the immunomodulatory therapies administered, demonstrating that patients with pediatric-onset immune dysregulation required more lines of treatment compared to those with adult-onset immune dysregulation. (A–C) Immunomodulant therapies and lines of treatment. MMF, mofetil mycophenolate; Nr, number.